DK-I Type Transcranial Magnetic Stimulator Technical Principle

The Transcranial Magnetic Stimulator (rTMS) is primarily used for treatment by altering its stimulation frequency to either excite or inhibit the function of specific areas of the cerebral cortex.

High-frequency, high-intensity rTMS can generate excitatory postsynaptic potential summation, leading to abnormal neural excitation at the stimulation site, whereas low-frequency stimulation has the opposite effect. It treats diseases by bidirectionally regulating the balance between brain excitation and inhibition. The local neural stimulation from rTMS affects functions in multiple areas through neural network connections and interactions. For different patients' brain functional conditions, adjustments in intensity, frequency, stimulation site, and coil direction are necessary to achieve optimal therapeutic outcomes.

DK-I TypeTranscranial Magnetic Stimulator Application Areas

TMS can treat mental disorders such as schizophrenia (negative symptoms), depression, obsessive-compulsive disorder, mania, and post-traumatic stress disorder (PTSD). Among these, the treatment for depression has been approved by the FDA in the United States, with a * rate of 20% and a treatment efficacy rate as high as 100%. In China, major psychiatric hospitals, including Guangzhou Brain Hospital, Hunan Brain Hospital, Shanghai Mental Health Center, Beijing Anding Hospital, and Peking University Sixth Hospital, have implemented related treatments and achieved promising clinical results.

It also shows significant effectiveness in spinal cord injury, Parkinson's disease (PD), epilepsy, post-stroke rehabilitation, peripheral nerve rehabilitation, and neuropathic pain. It is one of the few non-invasive devices in the field of treatment and rehabilitation.